GREAT POINT PARTNERS LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share (VTGN)

Filing Manager
GREAT POINT PARTNERS LLC
Reporting Manager
Great Point Partners, LLC
Security
Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
VTGN
Shares outstanding
32,736,210 shares
Disclosed Ownership
2,055,834 shares
Ownership
6.3%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 15:18:41 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GREAT POINT PARTNERS LLC disclosed 6.3% ownership in Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share (VTGN) on 30 Sep 2025."

Quick Takeaways

  • GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share (VTGN).
  • Disclosed ownership: 6.3%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 15:18.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Great Point Partners, LLC 6.3% 2,055,834 0 2,055,834 /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Dr. Jeffrey R. Jay, M.D. 6.3% 2,055,834 0 2,055,834 /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D
Ms. Lillian Nordahl 6.3% 2,055,834 0 2,055,834 /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl

Sponsored